A review of the FDA’s drug approvals of 2024 shows that small companies loomed large—both in the sheer number of nods g | ...
Chicago-based Meitheal Pharmaceuticals, along with its Chinese parent, was busy in 2024, adding both biosimilar drugs and ...
A consortium including scientists from the Tropical Institute at LMU University Hospital has demonstrated the effectiveness of a new antibiotic.
Scientists have collected troves of DNA and microscopic imaging data from human cells—and now they have a tool that might ...
New findings suggest that pet dogs may serve as an overlooked conduit for transferring antibiotic-resistant Salmonella to ...
The new site would include 22 multi-family units. The Ashworth building, Chatham Street Wine Market, Serendipity and Esteemed ...
In a bid to help the immune system of autoimmune disease patients reset, a San Francisco startup startup has raised $120 ...
Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...
Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...
FDA's Patrizia Cavazzoni to retire as CDER chief in 2nd senior official's departure in span of weeks
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...
Naturally, more work is needed. Although GLS -1 agonists have been used in diabetes for 20 years, some of the newer findings ...
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing Medicare to negotiate prices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback